Abstract
We report two children with systemic lupus erythematosus (SLE) having severe bleeding manifestations and lupus anticoagulant hypoprothrombinemia syndrome (LAHPS) along with a review of published cases of childhood SLE and LAHPS. We report clinical and laboratory profile of two children diagnosed with childhood SLE and LAHPS. We also conducted literature search to identify similar published cases and a review was performed. An 8-year-old girl had presented with fever, arthralgia, alopecia, anasarca and bleeding from multiple sites. She was diagnosed to have SLE based on laboratory investigations which showed anemia, thrombocytopenia, low complements, positive anti-nuclear antibody (ANA) and double standard DNA (dsDNA) antibodies. She was also found to have prolonged prothrombin time (PT) and activated partial thromboplastin time (aPTT), positive lupus anticoagulant (LA) and low factor II levels. She was diagnosed to have SLE with LAHPS and treated with intravenous methylprednisolone, intravenous immunoglobulin and cyclophosphamide with good outcome. Patient 2 was a 7-year-old-boy who was diagnosed to have SLE when he presented with fever, anasarca, malar rash, arthritis and bleeding from skin and mucosa. Laboratory investigations revealed anemia, proteinuria, low complements, positive ANA and anti-dsDNA titre. Coagulation studies showed deranged PT and aPTT, positive LA and low factor II levels. He was diagnosed to have SLE with LAHPS and was treated with intravenous methylprednisolone and oral mycophenolate mofetil. Review of literature of cases with childhood SLE and LAHPS showed that there are 32 cases have been reported till date which have been summarized. LAHPS is an uncommonly identified cause of bleeding in patients with SLE and must be suspected while evaluating these children.
Similar content being viewed by others
References
Tarr T, Dérfalvi B, Győri N, Szántó A, Siminszky Z, Malik A, Szabó AJ, Szegedi G, Zeher M (2015) Similarities and differences between pediatric and adult patients with systemic lupus erythematosus. Lupus 24:796–803
Fayyaz A, Igoe A, Kurien BT, Danda D, James JA, Stafford HA, Scofield RH (2015) Haematological manifestations of lupus. Lupus Sci Med. https://doi.org/10.1136/lupus-2014-000078
Martinez-Martinez MU, Sturbaum AK, Alcocer-Varela J et al (2014) Factors associated with mortality and infections in patients with systemic lupus erythematosus with diffuse alveolar hemorrhage. J Rheumatol 41:1656–1661
Ardoin SP, Schanberg LE (2012) Paediatric rheumatic disease: lessons from SLE: children are not little adults. Nat Rev Rheumatol 8:444–445
Aguiar CL, Soybilgic A, Avcin T, Myones BL (2015) Pediatric antiphospholipid syndrome. Curr Rheumatol Rep 17:27
Rapaport SI, Ames SB, Duvall BJ (1960) A plasma coagulation defect in systemic lupus erythematosus arising from hypoprothrombinemia combined with antiprothrombinase activity. Blood 15:212–227
Bajaj SP, Rapaport SI, Fierer DS, Herbst KD, Schwartz DB (1983) A mechanism for the hypoprothrombinemia of the acquired hypoprothrombinemia-lupus anticoagulant syndrome. Blood 61:684–692
Mulliez SMN, De Keyser F, Verbist C, Vantilborgh A, Wijns W, Beukinga I, Devreese KMJ (2015) Lupus anticoagulant-hypoprothrombinemia syndrome: report of two cases and review of the literature. Lupus 24:736–745
das Chagas Medeiros MM, Bezerra MC, Braga FNHF, da Justa Feijão MRM, Gois ACR, do Rebouças VC, de Carvalho R, Carvalho TMAZ, Ribeiro LNS ÁM (2016) Clinical and immunological aspects and outcome of a Brazilian cohort of 414 patients with systemic lupus erythematosus (SLE): comparison between childhood-onset, adult-onset, and late-onset SLE. Lupus 25:355–363
Groot N, de Graeff N, Avcin T et al (2017) European evidence-based recommendations for diagnosis and treatment of paediatric antiphospholipid syndrome: the SHARE initiative. Ann Rheum Dis 76:1637–1641
Eberhard A, Sparling C, Sudbury S, Ford P, Laxer R, Silverman E (1994) Hypoprothrombinemia in childhood systemic lupus erythematosus. Semin Arthritis Rheum 24:12–18
Baca V, Montiel G, Meillón L, Pizzuto J, Catalán T, Juan-Shum L, Nieva B (2002) Diagnosis of lupus anticoagulant in the lupus anticoagulant-hypoprothrombinemia syndrome: report of two cases and review of the literature. Am J Hematol 71:200–207
Sarker T, Roy S, Hollon W, Rajpurkar M (2015) Lupus anticoagulant acquired hypoprothrombinemia syndrome in childhood: two distinct patterns and review of the literature. Haemoph Off J World Fed Hemoph 21:754–760
Lee MT, Nardi MA, Hadzi-Nesic J, Karpatkin M (1996) Transient hemorrhagic diathesis associated with an inhibitor of prothrombin with lupus anticoagulant in a 1 1/2-year-old girl: report of a case and review of the literature. Am J Hematol 51:307–314
Mazodier K, Arnaud L, Mathian A et al (2012) Lupus anticoagulant-hypoprothrombinemia syndrome: report of 8 cases and review of the literature. Medicine (Baltimore) 91:251–260
Sreedharanunni S, Ahluwalia J, Kumar N, Bose SK, Dhawan R, Malhotra P (2017) Lupus anticoagulant—hypoprothrombinemia syndrome: a rare cause of intracranial bleeding. Blood Coagul Fibrinolysis Int J Haemost Thromb 28:416–418
Carvalho C, Viveiro C, Maia P, Rezende T (2013) Acquired antiprothrombin antibodies: an unusual cause of bleeding. BMJ Case Rep. https://doi.org/10.1136/bcr-2012-007948
Cetin Gedik K, Siddique S, Aguiar CL (2018) Rituximab use in pediatric lupus anticoagulant hypoprothrombinemia syndrome—report of three cases and review of the literature. Lupus 27:1190–1197
Bernstein ML, Salusinsky-Sternbach M, Bellefleur M, Esseltine DW (1984) Thrombotic and hemorrhagic complications in children with the lupus anticoagulant. Am J Dis Child 138:1132–1135
Vinet E, Rich E, Senécal J-L (2006) Thromboembolism complicating the treatment of lupus anticoagulant hypoprothrombinemia syndrome. J Rheumatol 33:2088–2090
Biggs R, Denson KWE The mode of action of a coagulation inhibitor in the blood of two patients with disseminated lupus erythematosus (DLE). Br J Haematol 10:198–216
Corrigan JJ, Patterson JH, May NE (1970) Incoagulability of the blood in systemic lupus erythematosus: a case due to hypoprothrombinemia and a circulating anticoagulant. Am J Dis Child 119:365–369
Natelson EA, Cyprus GS, Hettig RA (1976) Absent factor II in systemic lupus erythematosus. Immunologic studies and response to corticosteroid therapy. Arthritis Rheum 19:79–82
Lillquist KB, Dyerberg J, Krogh-Jensen M (1978) The absence of factor II in a child with systemic lupus erythematosus. Acta Paediatr Scand 67:533–536
Schwartz S, Esseltine DW (1984) Postextraction hemorrhage in a young male patient with systemic lupus erythematosus. Oral Surg Oral Med Oral Pathol 57:254–257
Grau E, Real E, Pastor E, Ivorra J, Quecedo E (1997) Prothrombin deficiency and hemorrhage associated with a lupus anticoagulant. Am J Hematol 54:85
Vivaldi P, Rossetti G, Galli M, Finazzi G (1997) Severe bleeding due to acquired hypoprothrombinemia-lupus anticoagulant syndrome. Case report and review of literature. Haematologica 82:345–347
Yacobovich JR, Uziel Y, Friedman Z, Radnay J, Wolach B (2001) Diffuse muscular haemorrhage as presenting sign of juvenile systemic lupus erythematosus and lupus anticoagulant hypoprothrombinaemia syndrome. Rheumatol Oxf Engl 40:585–587
Taddio A, Brescia AC, Lepore L, Rose’ CD (2007) Steady improvement of prothrombin levels after cyclophosphamide therapy in pediatric lupus anticoagulant hypoprothrombinemia syndrome (LAHPS). Clin Rheumatol 26:2167–2169
Favier R, Kheyar T, Renolleau S, Tabone MD, Favier M, Ulinski T (2012) Lupus anticoagulant-hypoprothrombinemia syndrome revealing systemic lupus in an 11-year old girl in a context of clinical and biological emergency. Ann Biol Clin (Paris) 70:226–230
Kim JS, Kim MJ, Bae EY, Jeong DC (2014) Pulmonary hemorrhage in pediatric lupus anticoagulant hypoprothrombinemia syndrome. Korean J Pediatr 57:202–205
Bhowmick R, Agarwal I, Arumugam V, Kumar TS (2018) Lupus anticoagulant-hypoprothrombinemia syndrome. Indian J Pediatr 85:392–393
Foord A, Baca N, Buchbinder D, Mahajerin A (2017) Lupus anticoagulant hypoprothrombinemia syndrome associated with severe thrombocytopenia in a child. Pediatr Blood Cancer. https://doi.org/10.1002/pbc.26357
Komvilaisak P, Wisanuyotin S, Jettrisuparb A, Wiangnon S (2017) Lupus anticoagulant-hypoprothrombinemia syndrome (LAC-HPS) in children with systemic lupus erythematosus: report of 3 cases. J Pediatr Hematol Oncol 39:e521–e524
Author information
Authors and Affiliations
Contributions
RKP: writing of initial draft of manuscript, editing and revision of manuscript at all stages of its production, review of literature and management of patients. AKJ/AS/PS/SG: contributed to editing of manuscript, review of literature and management of patients. NK/AR/JA/SS: critically revised the manuscript, review of literature and management of patients. DS: critically revised the manuscript at all stages of its production, final approval of manuscript, review of literature and management of patients.
Corresponding author
Ethics declarations
Conflict of interest
All authors declare no conflict of interest.
Ethical standards
The study complies with the Declaration of Helsinki. The study was approved by Department Review Board (DRB), Department of Pediatrics, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Informed consent
An informed consent was obtained from parents of the patients for publication.
Rights and permissions
About this article
Cite this article
Pilania, R.K., Suri, D., Jindal, A.K. et al. Lupus anticoagulant hypoprothrombinemia syndrome associated with systemic lupus erythematosus in children: report of two cases and systematic review of the literature. Rheumatol Int 38, 1933–1940 (2018). https://doi.org/10.1007/s00296-018-4127-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-018-4127-9